Related Articles
ERCC1 and XRCC1 expression predicts survival in bladder cancer patients receiving combined trimodality therapy
The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin‑based adjuvant chemotherapy
Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression
Excision repair cross complementing-group 1: Gene expression and platinum resistance (Review) parameters in human breast cancer
Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy